AllStar Health Brands(ALST)
$0.00+0.00 (+16.67%)
ALST
AllStar Health Brands financials statements
$0.00
At close:+0.00 (+16.67%)
AllStar Health Brands (ALST) Ratios
11 Followers
AllStar Health Brands Ratios
ALST's free cash flow for Q3 2026 was $12.40K. For the 2026 fiscal year, ALST's free cash flow was decreased by $-4.00 and operating cash flow was $12.40K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.13 | -0.04 | -0.04 | -0.15 | -0.43 |
| Operating Cash Flow Ratio | -0.04 | -0.01 | -0.03 | -0.03 | -0.08 |
| Short-Term Operating Cash Flow Coverage | -0.17 | -0.02 | -0.11 | -0.13 | -0.36 |
| Net Current Asset Value | $ -10.73M | $ -9.30M | $ -8.83M | $ -8.85M | $ -8.49M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 14687.58 | 10046.75 | 1372.70 | 1048.07 | 77.54 |
| Debt-to-Equity Ratio | -0.26 | -0.24 | -0.25 | -0.23 | -0.22 |
| Debt-to-Capital Ratio | -0.35 | -0.31 | -0.34 | -0.29 | -0.29 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Debt Service Coverage Ratio | -0.08 | -0.03 | -0.05 | -0.38 | -1.63 |
| Interest Coverage Ratio | -0.29 | -0.84 | -0.74 | -0.55 | -1.14 |
| Debt to Market Cap | 20.17 | 13.34 | 16.33 | 6.47 | 9.47 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.02 | 0.09 | 0.45 |
| Net Debt to EBITDA | -8.58 | -29.91 | -18.40 | -2.22 | -0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 100.00% | 82.45% | 24.62% |
| EBIT Margin | 0.00% | 0.00% | -379390.22% | -5705.80% | -1463.01% |
| EBITDA Margin | 0.00% | 0.00% | -131036.96% | -4519.69% | -1380.43% |
| Operating Profit Margin | 0.00% | 0.00% | -205891.30% | -1064.33% | -96.38% |
| Pretax Profit Margin | 0.00% | 0.00% | -658250.00% | -7630.18% | -1547.77% |
| Net Profit Margin | 0.00% | 0.00% | -658250.00% | -7630.18% | -1547.77% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -658250.00% | -7630.18% | -1547.77% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 440.82% | 231.45% | 319.71% | 716.90% | 1605.86% |
| Return on Assets (ROA) | -754868.25% | -226974.09% | -37474.63% | -79590.17% | -15793.58% |
| Return on Equity (ROE) | 13.30% | 5.37% | 6.86% | 17.19% | 45.55% |
| Return on Capital Employed (ROCE) | 3.02% | 2.32% | 2.14% | 2.40% | 2.84% |
| Return on Invested Capital (ROIC) | 4.07% | 3.04% | 2.86% | 3.10% | 3.65% |
| Return on Tangible Assets | -754868.25% | -226974.09% | -37474.63% | -79590.17% | -15793.58% |
| Earnings Yield | -1036.79% | -301.47% | -445.70% | -491.64% | -1929.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.06 | 10.43 | 10.20 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | -0.00 | -0.00 | -0.03 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -143654.30 | -2058.37 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 143654.30 | 2058.37 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.15 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -60361.51 | 0.00 | -172155.97 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -60361.51 | 0.00 | -172155.97 |
| Operating Cash Flow Coverage Ratio | -0.17 | -0.02 | -0.11 | -0.13 | -0.36 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -2624.41 | -12.91 | -2.76 |
| Free Cash Flow Yield | -344.35% | -30.75% | -177.70% | -83.19% | -343.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.10 | -0.33 | -0.22 | -0.20 | -0.05 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 1476.89 | 15.52 | 0.80 |
| Price-to-Book (P/B) Ratio | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.29 | -3.25 | -0.56 | -1.20 | -0.29 |
| Price-to-Operating Cash Flow Ratio | -0.29 | -3.25 | -0.56 | -1.20 | -0.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | -9.00 | -32.15 | -19.53 | -2.57 | -0.61 |
| Enterprise Value | 2.91M | 2.38M | 2.35M | 2.31M | 2.10M |
| EV to EBITDA | -9.00 | -32.15 | -19.53 | -2.57 | -0.61 |
| EV to Sales | 0.00 | 0.00 | 25587.21 | 115.98 | 8.40 |
| EV to Free Cash Flow | -6.15 | -46.65 | -9.75 | -8.98 | -3.05 |
| EV to Operating Cash Flow | -6.15 | -46.65 | -9.75 | -8.98 | -3.05 |
| Tangible Book Value Per Share | -0.04 | -0.04 | -0.07 | -0.33 | -1.80 |
| Shareholders’ Equity Per Share | -0.04 | -0.04 | -0.07 | -0.33 | -1.80 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Net Income Per Share | -0.01 | -0.00 | -0.00 | -0.06 | -0.82 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 4.41 | 2.07 | 1.74 | 1.34 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.33 | 0.10 | 0.40 | 0.82 | 1.89 |
Currency in USD

